Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Needle-free Injection Systems Market by Product (Fillable and Prefilled), Source of Power (Spring-based Injector Systems and Gas Propelled/Air Forced Injector Systems), Type (Liquid-based, Projectile/Depot-based, and Powder-based), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, and Pain Management), and End User (Hospitals & Clinics, Home Care Settings, and Research Laboratories) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_172129
Pages: 163
Aug 2017 | 2771 Views
face gplus_n
Author's : Prateeksha Kaul & Pallavi Jaiswal
Tables: 78
Charts: 33
twit_n pr_n

Needle-free Injection Systems Market Overview:

Global Needle-free Injection Systems Market was valued at $8,166 million in 2016, and is estimated to reach $23,116 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. Needle-free injection systems are used to administer liquid formulations, drugs, and vaccines into patients without piercing the skin with a conventional needle. The demand for these systems has increased considerably in the recent years as they improve immune response to vaccines, eliminate risks of needles, and reduce healthcare costs. However, lack of skilled professionals and the restricted use of needle-free injection systems for intravenous administration impede the market growth.

Rise in Diabetic Population

Rise in prevalence of diabetes raises the demand for needle-free insulin delivery devices. According to the Centers for Disease Control and Prevention, in 2015, approximately 30.3 million people or 9.4% of the total population of the U.S. suffered with diabetes. In addition, according to the Diabetes UK, in 2016, approximately 3.6 million people were diagnosed with diabetes in the UK. Hence, increase in diabetics is expected to have a positive impact on the market.

Growth in Asia-Pacific

Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and growth in awareness about the benefits of needle-free injections and their application in treatment of cancer, diabetes, and other infectious diseases.

Benefits of Needle-free Injection Systems

Needle-free injection systems ensure faster drug delivery and better reproducibility as compared to invasive drug delivery systems. In addition, needle-free injection systems also eliminate the needle phobia and enable self-administration of drugs.

Global Needle-free Injection Systems: Market Segmentation

GLOBAL NEEDLE-FREE INJECTION SYSTEMS: MARKET SEGMENTATION

Get more information on this report : Request Sample Pages

The global needle free injection system market is segmented on the basis of product, source of power, type, usability, site of delivery, application, end user, and region. Based on product, the market is classified into fillable and prefilled needle-free injection systems. By source of power, it is divided into spring-based and gas-propelled/air forced injector systems. According to type, it is segmented into liquid-based, projectile/depot-based, and powder-based. By usability, it is bifurcated into disposable and reusable needle-free injectors. On the basis of site of delivery, the market is categorized into subcutaneous, intramuscular, and intradermal injectors. Based on application, it is segmented into vaccine delivery, insulin delivery, pain management, and others. According to the end user, the market is classified into hospitals & clinics, home care settings, research laboratories, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies operating in the market include Antares Pharma, Inc., PharmaJet, PenJet Corporation, Medical International Technology, Inc., INJEX Pharma AG, Crossject needle-free injection systems, National Medical Products Inc., Valeritas, Inc., and European Pharma Group.

South Africa Needle-free Injection Systems Market, 2016-2023 ($Million)

South Africa Needle-free Injection Systems Market, 2016-2023 ($Million)

Get more information on this report : Request Sample Pages

Key Benefits:

The study provides an in-depth analysis of the global needle-free injection systems market, with current trends and future estimations, to elucidate the imminent investment pockets.
Quantitative analysis from 2016 to 2023 of all geographical regions is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Needle-free Injection Systems Market Key Segments:

By Product

  • Fillable
  • Prefilled

By Source of Power

  • Spring-based Injector Systems
  • Gas Propelled/Air Forced Injector Systems

By Type

  • Liquid-based
  • Projectile/Depot-based
  • Powder-based

By Usability

  • Disposable
  • Reusable

By Site of Delivery

  • Subcutaneous Injectors
  • Intramuscular Injectors
  • Intradermal Injectors

By Application

  • Vaccine Delivery
  • Insulin Delivery
  • Pain Management
  • Others

By End User

  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Improved Immunization Coverage
3.3.1.2. Eliminate Risks of Needles
3.3.1.3. Reduce Health Care Costs
3.3.1.4. Increase in patient power

3.3.2. Restrains

3.3.2.1. Dearth of trained personnel
3.3.2.2. Limitation in intravenous administration

3.3.3. Opportunities

3.3.3.1. Wide range of applications
3.3.3.2. Technological advancements

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

Chapter: 4 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. FILLABLE NEEDLE-FREE INJECTORS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PREFILLED NEEDLE-FREE INJECTORS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. SPRING-BASED NEEDLE-FREE INJECTORS

5.2.1. Market size and forecast

5.3. GAS PROPELLED/ AIR FORCED INJECTOR SYSTEMS

5.3.1. Market size and forecast

Chapter: 6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. LIQUID-BASED NEEDLE FREE INJECTORS

6.2.1. Market size and Forecast

6.3. PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS

6.3.1. Market size and forecast

6.4. POWDER-BASED NEEDLE FREE INJECTORS

6.4.1. Market size and forecast

Chapter: 7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. SUBCUTANEOUS INJECTORS

7.2.1. Market size and forecast

7.3. INTRAMUSCULAR INJECTORS

7.3.1. Market size and forecast

7.4. INTRADERMAL INJECTORS

7.4.1. Market size and forecast

Chapter: 8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. DISPOSABLE NEEDLE-FREE INJECTORS

8.2.1. Market size and forecast

8.3. REUSABLE NEEDLE-FREE INJECTORS

8.3.1. Market size and forecast

Chapter: 9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. VACCINE DELIVERY

9.2.1. Market size and forecast

9.3. INSULIN DELIVERY

9.3.1. Market size and forecast

9.4. PAIN MANAGEMENT

9.4.1. Main size and forecast

9.5. OTHER APPLICATIONS

9.5.1. Market size and forecast

Chapter: 10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER

10.1. OVERVIEW

10.1.1. Market size and forecast

10.2. HOSPITALS AND CLINICS

10.2.1. Market size and forecast

10.3. HOME CARE SETTINGS

10.3.1. Market size and forecast

10.4. RESEARCH LABORATORIES

10.4.1. Market size and forecast

10.5. OTHER END USERS

10.5.1. Market size and forecast

Chapter: 11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION

11.1. OVERVIEW

11.1.1. Market size and forecast

11.2. NORTH AMERICA

11.2.1. Key market trends
11.2.2. Growth factors and opportunities
11.2.3. Market size and forecast

11.2.3.1. U.S. market size and forecast
11.2.3.2. Canada market size and forecast
11.2.3.3. Mexico market size and forecast

11.3. EUROPE

11.3.1. Key market trends
11.3.2. Growth factors and opportunities
11.3.3. Market size and forecast

11.3.3.1. Germany market size and forecast
11.3.3.2. France market size and forecast
11.3.3.3. UK market size and forecast
11.3.3.4. Italy market size and forecast
11.3.3.5. Spain market size and forecast
11.3.3.6. Rest of Europe market size and forecast

11.4. ASIA-PACIFIC

11.4.1. Key market trends
11.4.2. Growth factors and opportunities
11.4.3. Market size and forecast

11.4.3.1. Japan market size and forecast
11.4.3.2. China market size and forecast
11.4.3.3. India market size and forecast
11.4.3.4. Australia market size and forecast
11.4.3.5. South Korea market size and forecast
11.4.3.6. Rest of Asia-Pacific market size and forecast

11.5. LAMEA

11.5.1. Key market trends
11.5.2. Growth factors and opportunities
11.5.3. Market size and forecast

11.5.3.1. Brazil market size and forecast
11.5.3.2. South Africa market size and forecast
11.5.3.3. Saudi Arabia market size and forecast
11.5.3.4. Rest of LAMEA market size and forecast

Chapter: 12 COMPANY PROFILES

12.1. ANTARES PHARMA, INC.

12.1.1. Company overview
12.1.2. Company snapshot
12.1.3. Operating business segments
12.1.4. Product portfolio
12.1.5. Business performance
12.1.6. Key strategic moves and developments

12.2. CROSSJECT NEEDLE FREE INJECTION SYSTEMS

12.2.1. Company overview
12.2.2. Company snapshot
12.2.3. Operating business segments

12.3. INJEX PHARMA AG

12.3.1. Company overview
12.3.2. Company snapshot
12.3.3. Operating business segments
12.3.4. Product portfolio

12.4. MEDICAL INTERNATIONAL TECHNOLOGY, INC.

12.4.1. Company overview
12.4.2. Company snapshot
12.4.3. Operating business segments
12.4.4. Product portfolio

12.5. NATIONAL MEDICAL PRODUCTS, INC.

12.5.1. Company overview
12.5.2. Company snapshot
12.5.3. Operating business segments
12.5.4. Product portfolio

12.6. PHARMAJET

12.6.1. Company overview
12.6.2. Company snapshot
12.6.3. Operating business segments
12.6.4. Key strategic moves and developments

12.7. THE EUROPEAN PHARMA GROUP

12.7.1. Company overview
12.7.2. Company snapshot
12.7.3. Operating business segments
12.7.4. Product portfolio
12.7.5. Business performance

12.8. VALERITAS HOLDINGS, INC.

12.8.1. Company overview
12.8.2. Company snapshot
12.8.3. Operating business segments
12.8.4. Business performance

 LIST OF TABLES

TABLE 1. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. FILLABLE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. PREFILLED NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 4. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023, ($MILLION)
TABLE 5. SPRING-BASED NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 6. GAS PROPELLED/AIR FORCED NEEDLE-FREE INJECTION SYSTEMS, BY REGION, 2016-2023, ($MILLION)
TABLE 7. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 8. LIQUID-BASED NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 9. PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 10. POWDER-BASED NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 11. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023, ($MILLION)
TABLE 12. SUBCUTANEOUS NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 13. INTRAMUSCULAR NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 14. INTRADERMAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 15. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023, ($MILLION)
TABLE 16. DISPOSABLE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 17. REUSABLE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 18. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023, ($MILLION)
TABLE 19. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR VACCINE DELIVERY, BY REGION, 2016-2023, ($MILLION)
TABLE 20. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INSULIN DELIVERY, BY REGION, 2016-2023, ($MILLION)
TABLE 21. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR PAIN MANAGEMENT, BY REGION, 2016-2023, ($MILLION)
TABLE 22. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2023, ($MILLION)
TABLE 23. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END-USER, 2016-2023, ($MILLION)
TABLE 24. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023, ($MILLION)
TABLE 25. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016-2023, ($MILLION)
TABLE 26. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2016-2023, ($MILLION)
TABLE 27. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR OTHER END USER, BY REGION, 2016-2023, ($MILLION)
TABLE 28. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 29. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 30. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 33. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023, ($MILLION)
TABLE 34. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023, ($MILLION)
TABLE 35. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023, ($MILLION)
TABLE 36. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END-USER, 2016-2023, ($MILLION)
TABLE 37. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 38. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 39. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023, ($MILLION)
TABLE 40. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 41. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023, ($MILLION)
TABLE 42. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023, ($MILLION)
TABLE 43. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023, ($MILLION)
TABLE 44. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END-USER, 2016-2023, ($MILLION)
TABLE 45. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 46. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 47. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023, ($MILLION)
TABLE 48. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 49. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023, ($MILLION)
TABLE 50. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023, ($MILLION)
TABLE 51. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023, ($MILLION)
TABLE 52. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END-USER, 2016-2023, ($MILLION)
TABLE 53. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 54. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023, ($MILLION)
TABLE 55. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023, ($MILLION)
TABLE 56. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 57. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023, ($MILLION)
TABLE 58. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023, ($MILLION)
TABLE 59. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023, ($MILLION)
TABLE 60. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END-USER, 2016-2023, ($MILLION)
TABLE 61. ANTARES PHARMA: COMPANY SNAPSHOT
TABLE 62. ANTARES PHARMA: OPERATING SEGMENTS
TABLE 63. ANTARES PHARMA: PRODUCT PORTFOLIO
TABLE 64. CROSSJECT: COMPANY SNAPSHOT
TABLE 65. CROSSJECT: PRODUCT PORTFOLIO
TABLE 66. INJEX PHARMA AG: COMPANY SNAPSHOT
TABLE 67. INJEX: OPERATING SEGMENTS
TABLE 68. INJEX PHARMA AG: PRODUCT PORTFOLIO
TABLE 69. MEDICAL INTERNATIONAL TECHNOLOGY: COMPANY SNAPSHOT
TABLE 70. MEDICAL INTERNATIONAL TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 71. NATIONAL MEDICAL PRODUCT: COMPANY SNAPSHOT
TABLE 72. NATIONAL MEDICAL PRODUCT: PRODUCT PORTFOLIO
TABLE 73. PHARMAJET: COMPANY SNAPSHOT
TABLE 74. PHARMAJET: PRODUCT PORTFOLIO
TABLE 75. EUROPEAN PHARMA GROUP: COMPANY SNAPSHOT
TABLE 76. EUROPEAN PHARMA GROUP: PRODUCT PORTFOLIO
TABLE 77. VALERITAS: COMPANY SNAPSHOT
TABLE 78. VALERITAS: PRODUCT PORTFOLIO

 LIST OF FIGURES

FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 5. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 7. TOP INVESTMENT POCKETS
FIGURE 8. CAUSES OF NEEDLE STICK INJURIES, TANZANIA, 2015
FIGURE 9. IMPACT ANALYSIS, 2016
FIGURE 10. MARKET SHARE ANALYSIS, 2016
FIGURE 11. DISTRIBUTION OF NEEDLE-FREE INJECTION SYSTEMS CLINICAL TRIALS, BY PHASE
FIGURE 12. U.S. NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 13. CANADA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023, ($MILLION)
FIGURE 14. MEXICO NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023, ($MILLION)
FIGURE 15. GERMANY NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 16. FRANCE NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 17. UK NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 18. ITALY NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 19. SPAIN NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 20. REST OF EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 21. JAPAN NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 22. CHINA NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 23. INDIA NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 24. AUSTRALIA NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 25. SOUTH KOREA NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 27. BRAZIL NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 28. SOUTH AFRICA NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 29. SAUDI ARABIA NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 30. REST OF LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, 2016-2023, ($MILLION)
FIGURE 31. ANTARES PHARMA: NET SALES, 2016-2023 ($MILLION)
FIGURE 32. ANTARES PHARMA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 33. VALERITAS: NET SALES, 2015-2016 ($MILLION)

 

Globally, chronic disorders, such as diabetes, typhoid, and Hepatitis A, constitute a major proportion of health and economic burden. Moreover, increase in incidence of needle-stick injuries leads to high risk of exposure to blood-borne pathogens such as HIV and hepatitis B and/or C. Hence, the adoption of needle-free syringes is vital for a safe and effective method of administration of vaccines and drugs into the patient.

Surge in the incidence of disorders, such as typhoid, and reduction in healthcare costs due to the use of needle-free injectors and elimination of risk of needles have led to increase in demand for these systems. In addition, benefits of needle-free injection systems, such as feasible self-administration of drugs, further fuels the market growth.

Asia-Pacific, especially emerging countries, such as China and India, possesses high growth potential due to rapid increase in geriatric population and rise in incidence of chronic diseases such as diabetes.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Needle-free Injection Systems Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo